Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study

Objectives To characterise peripheral musculoskeletal involvement in patients with spondyloarthritis (SpA) including psoriatic arthritis (PsA), across the world. Methods Cross-sectional study with 24 participating countries. Patients with a diagnosis of axial SpA (axSpA), peripheral SpA (pSpA) or Ps...

Full description

Autores:
López Medina, Clementina
Molto, Anna
Sieper, Joachim
Duruöz, Tuncay
Kiltz, Uta
Elzorkany, Bassel
Hajjaj Hassouni, Najia
Burgos Vargas, Ruben
Maldonado Cocco, José
Ziade, Nelly
Gavali, Meghna
Navarro Compan, Victoria
Luo, Shue Fen
Monti, Sara
Tae Jong, Kim
Kishimoto, Mitsumasa
Pimentel Santos, F M
Gu, Jieruo
Schiotis, Ruxandra
van Gaalen, Floris A
Geher, Pál
Magrey, Marina
Ibáñez Vodnizza, Sebastián E
Bautista Molano, Wilson
Maksymowych, Walter
Machado, Pedro M
Landewé, Robert
van der Heijde, Desirée
Dougados, Maxime
Tipo de recurso:
Article of journal
Fecha de publicación:
2021
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/5890
Acceso en línea:
http://hdl.handle.net/20.500.12495/5890
https://doi.org/10.1136/RMDOPEN-2020-001450
Palabra clave:
Ankylosing
Arthritis
Juvenile
Psoriatic
Spondylitis
Rights
openAccess
License
Atribución-NoComercial 4.0 Internacional
Description
Summary:Objectives To characterise peripheral musculoskeletal involvement in patients with spondyloarthritis (SpA) including psoriatic arthritis (PsA), across the world. Methods Cross-sectional study with 24 participating countries. Patients with a diagnosis of axial SpA (axSpA), peripheral SpA (pSpA) or PsA according to their rheumatologist were included. The investigators were asked which diagnosis out of a list of six (axSpA, PsA, pSpA, inflammatory bowel disease-associated SpA,reactive arthritis or juvenile SpA (Juv-SpA)) fitted the patient best. Peripheral manifestations (ie, peripheral joint disease, enthesitis, dactylitis and root joint disease), their localisation and treatments were evaluated. Results A total of 4465 patients were included (61% men, mean age 44.5 years) from four geographic areas: Latin merica (n=538), Europe plus North America (n=1677), Asia (n=975) and the Middle East plus North Africa (n=1275). Of those, 78% had ever suffered from at least one peripheral musculoskeletal manifestation; 57% had peripheral joint disease, 44% had enthesitis and 15% had dactylitis. Latin American had far more often peripheral joint disease (80%) than patients from other areas. Patients with PsA had predominantly upper limb and small joint involvement (52%). Hip and shoulder involvement was found in 34% of patients. The prevalence of enthesitis ranged between 41% in patients with axSpA and 65% in patients with Juv-SpA. Dactylitis was most frequent among patients with PsA (37%). Conclusion These results suggest that all peripheral features can be found in all subtypes of SpA, and that differences are quantitative rather than qualitative. In a high proportion of patients, axial and peripheral manifestations coincided. These findings reconfirm SpA clinical subtypes are descendants of the same underlying disease, called SpA.